A weekly dosage of 150 milligrams of testosterone is a common starting point for testosterone replacement therapy (TRT) in individuals diagnosed with hypogonadism. This regimen aims to restore physiological testosterone levels, potentially alleviating symptoms such as fatigue, low libido, and decreased muscle mass. Individual responses can vary, and subsequent dose adjustments may be necessary based on bloodwork and clinical assessment.
Restoring testosterone to normal levels can offer significant improvements in quality of life for those with a deficiency. Potential benefits include increased energy levels, improved mood, enhanced cognitive function, and increased bone density. Historically, testosterone replacement therapy has evolved significantly, with advancements in delivery methods and monitoring protocols contributing to safer and more effective treatment strategies.